Effect of follicle-stimulating hormone receptor N680S polymorphism on the efficacy of follicle-stimulating hormone stimulation on donor ovarian response

Pharmacogenetics and Genomics

Volumn 23, Issue 5, 2013, Pages 262-268

  Lledo, Belen ^a   Guerrero, Jaime ^b   Turienzo, Azahara ^a   Ortiz, Jose A ^a   Morales, Ruth ^a   Ten, Jorge ^b   Llacer, Joaquin ^b   Bernabeu, Rafael ^a,b  

^a Instituto Bernabeu   (Spain)

^b Instituto Bernabeu of Fertility and Gynecology   (Spain)

Author keywords

controlled ovarian hyperstimulation; FSHR; N680S; single nucleotide polymorphisms

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN BETA SUBUNIT; FOLLITROPIN; FOLLITROPIN RECEPTOR; FOSTIPUR; TRIPTORELIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DNA POLYMORPHISM; DONOR; EMBRYO TRANSFER; ENDOMETRIUM; FEMALE; FEMALE FERTILITY; FOLLICULAR PHASE; GENOTYPE; HORMONAL REGULATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; NIDATION; OOCYTE DONATION; OVARY CYCLE; OVARY HYPERSTIMULATION; PREDICTION; PREGNANCY RATE; PRIORITY JOURNAL; PROGNOSIS; SPONTANEOUS ABORTION; TREATMENT OUTCOME;

EID: 84876291407     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e32835fe813     Document Type: Article

References (35)

1. Mutsatsa S, Currid TJ. Pharmacogenetics: a reality or misplaced optimism? J Psychiatr Ment Health Nurs 2012. doi: 10.1111/j.1365-2850.2012.01910.x.
2. Loutradis D, Vlismas A, Drakakis P, Antsaklis A. Pharmacogenetics in ovarian stimulation-current concepts. Ann N Y Acad Sci 2008; 1127: 10-19.
3. Wang J, Pang GS, Chong SS, Lee CG. SNP web resources and their potential applications in personalized medicine. Curr Drug Metab 2012; 13:978-990.
4. Dupakuntla M, Mahale SD. Accessibility of the extracellular loops of follicle stimulating hormone receptor and their role in hormone-receptor interaction. Mol Cell Endocrinol 2010; 315:131-137.
5. Gromoll J, Ried T, Holtgreve-Grez H, Nieschlag E, Gudermann T. Localization of the human FSH receptor to chromosome 2 p21 using a genomic probe comprising exon 10. J Mol Endocrinol 1994; 12:265-271. (Pubitemid 24199696)
6. Simoni M, Gromoll J, Nieschlag E. The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocr Rev 1997; 18:739-773. (Pubitemid 28009566)
7. Oehninger S. Ovulation induction in IVF. Minerva Ginecol 2011; 63: 137-156.
8. Kligman I, Rosenwaks Z. Differentiating clinical profiles: predicting good responders, poor responders, and hyperresponders. Fertil Steril 2001; 76:1185-1190. (Pubitemid 33116384)
9. Coccia ME, Rizzello F. Ovarian reserve. Ann N Y Acad Sci 2008; 1127:27-30. (Pubitemid 351563104)
10. Freour T, Masson D, Mirallie S, Jean M, Bach K, Dejoie T, Barriere P. Active smoking compromises IVF outcome and affects ovarian reserve. Reprod Biomed Online 2008; 16:96-102. (Pubitemid 351187378)
11. Haller K, Salumets A, Uibo R. Anti-FSH antibodies associate with poor outcome of ovarian stimulation in IVF. Reprod Biomed Online 2008; 16:350-355. (Pubitemid 351419453)
12. Fauser BC, Diedrich K, Devroey P. Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation. Hum Reprod Update 2008; 14:1-14.
13. Simoni M, Tempfer CB, Destenaves B, Fauser BC. Functional genetic polymorphisms and female reproductive disorders: Part I: polycystic ovary syndrome and ovarian response. Hum Reprod Update 2008; 14:459-484.
14. Altmäe S, Hovatta O, Stavreus-Evers A, Salumets A. Genetic predictors of controlled ovarian hyperstimulation: where do we stand today? Hum Reprod Update 2011; 17:813-828.
15. Yao Y, Ma CH, Tang HL, Hu YF. Influence of follicle-stimulating hormone receptor (FSHR) Ser680Asn polymorphism on ovarian function and in-vitro fertilization outcome: a meta-analysis. Mol Genet Metab 2011; 103:388-393.
16. Laan M, Grigorova M, Huhtaniemi IT. Pharmacogenetics of folliclestimulating hormone action. Curr Opin Endocrinol Diabetes Obes 2012; 19:220-227.
17. Perez Mayorga M, Gromoll J, Behre HM, Gassner C, Nieschlag E, Simoni M. Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J Clin Endocrinol Metab 2000; 85: 3365-3369.
18. Behre HM, Greb RR, Mempel A, Sonntag B, Kiesel L, Kaltwasser P, et al. Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation. Pharmacogenet Genomics 2005; 15:451-456. (Pubitemid 41017593)
19. Binder H, Strick R, Zaherdoust O, Dittrich R, Hamori M, Beckmann MW, Oppelt PG. Assessment of FSHR variants and antimü llerian hormone in infertility patients with a reduced ovarian response to gonadotropin stimulation. Fertil Steril 2012; 97:1169-1175.
20. Mohiyidden L, NewmanWG, McBurney H, Mulugeta B, Roberts SA, Nardo LG. Follicle-stimulating hormone receptor gene polymorphisms are not associated with ovarian reserve markers. Fertil Steril 2012; 97:677-681.
21. Bernabeu R, Roca M, Torres A, Ten J. Indomethacin effect on implantation rates in oocyte recipients. Hum Reprod 2006; 21:364-369. (Pubitemid 43159908)
22. Aitomä ki K, Pakarinen P, Sistonen P, Tapanainen J, Gromoll J. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 1995; 82:959-968.
23. Jun JK, Yoon JS, Ku SY, Choi YM, Hwang KR, Park SY, et al. Follicle stimulating hormone receptor gene polymorphism and ovarian response to controlled ovarian hyperstimulation for IVF-ET. J Hum Genet 2006; 51:665-670. (Pubitemid 44325666)
24. Sudo S, Kudo M, Wada S, Sato O, Hsueh AJ, Fujimoto S. Genetic and functional analyses of polymorphisms in the human FSH receptor gene. Mol Hum Reprod 2006; 8:893-899.
25. De Castro F, Moron FJ, Montoro L, Galan JJ, Hernandez DP, Padilla ES, et al. Human controlled ovar?́an hyperstimulation outcome is a polygenic trait. Pharmacogenetics 2004; 14:285-293. (Pubitemid 38638915)
26. Sheikhha MH, Eftekhar M, Kalantar SM. Investigating the association between polymorphism of follicle-stimulating hormone receptor gene and ovarian response in controlled ovarian hyperstimulation. J Hum Reprod Sci 2011; 4:86-90.
27. De Castro F, Ruiz R, Montoro L, Perez-Hernandez D, Sanchez-Casas Padilla E, Real LM, et al. Role of follicle-stimulating hormone receptor Ser680Asn polymorphism in the efficacy of follicle stimulating hormone. Fertil Steril 2003; 80:571-576. (Pubitemid 37102868)
28. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update 2006; 12:685-718. (Pubitemid 44605509)
29. Fortune JE, Yang MY, Muruvi W. The earliest stages of follicular development: follicle formation and activation. Soc Reprod Fertil Suppl 2010; 67:203-216.
30. Pellatt L, Rice S, Dilaver N, Heshri A, Galea R, Brincat M, et al. Anti-Mü llerian hormone reduces follicle sensitivity to follicle-stimulating hormone in human granulosa cells. Fertil Steril 2011; 96:1246-1251.
31. Greb RR, Grieshaber K, Gromoll J, Sonntag B, Nieschlag E, Kiesel L, Simoni M. A common single nucleotide polymorphism in exon 10 of the human follicle stimulating hormone receptor is a major determinant of length and hormonal dynamics of the menstrual cycle. J Clin Endocrinol Metab 2005; 90:4866-4872. (Pubitemid 41159384)
32. Klinkert ER, Velde ER,Weima S, van Zandvoort PM, Hanssen RG, Nilsson PR, et al. FSH receptor genotype is associated with pregnancy but not with ovarian response in IVF. Reprod Biomed Online 2006; 13:687-695. (Pubitemid 44760893)
33. Dipple KM, Phelan JK, McCabe ERB. Consequences of complexity within biological networks: robustness and health or vulnerability and disease. Mol Genet Metab 2001; 74:45-50. (Pubitemid 32955146)
34. Morón FJ, de Castro F, Royo JL, Montoro L, Mira E, Sáez ME, et al. Bone morphogenetic protein 15 (BMP15) alleles predict over-response to recombinant follicle stimulation hormone and iatrogenic ovarian hyperstimulation syndrome (OHSS). Pharmacogenet Genomics 2006; 16:485-495. (Pubitemid 43922346)
35. Twigt JM, Hammiche F, Sinclair KD, Beckers NG, Visser JA, Lindemans J, et al. Preconception folic acid use modulates estradiol and follicular responses to ovarian stimulation. J Clin Endocrinol Metab 2011; 96:E322-E329.